MAPT and Alzheimer disease: Similarly, S100A9 was found to be strongly increased in brain lysates of both AD patients and AD mice (Chang et al., 2012; Kummer et al., 2012) and also in activated microglia and neurons with tau NFTs (Shepherd et al., 2006).